SECfiling News & Analysis
3 articles
Market Mood
UroGen Pharma (URGN) CMO Sells 5,222 Shares for $143,000
Mark Schoenberg, CMO of UroGen Pharma Ltd. (URGN), sold 5,222 shares for approximately $143,000, as reported in a SEC Form 4 filing. Following the transaction, his direct ownership consists of 139,763 shares valued at about $3.81 million. This sale represents a 25.81% decrease in Schoenberg's direct holdings over the past year, where he has completed seven sell transactions. The shares were sold at a weighted average price of $27.30 amid a 168.23% one-year total return as of June 12, 2026.
Read More
CLOA Position Increases by 63,417 Shares Valued at $3.3M
Inspirion Wealth Advisors increased its position in the iShares AAA CLO Active ETF (CLOA) by 63,417 shares, equating to an estimated value of $3.3 million, according to a recent SEC filing dated April 8, 2026. Following this transaction, CLOA now comprises 3.64% of Inspirion's reportable assets. As of April 7, 2026, CLOA shares reported a 6.3% increase over the past year, despite trailing the S&P 500 by 31 percentage points. The fund's objective is to provide capital preservation and current income with a 5.2% dividend yield, targeting income-seeking investors.
Read More
London Co Sells $51M Stake in Armstrong World Industries Shares
On February 17, 2026, London Co of Virginia disclosed the sale of 269,356 shares of Armstrong World Industries (NYSE:AWI) for an estimated $51.40 million. This sale, recorded in an SEC filing, reduced their stake to 2.06% of the fund’s reportable assets. The sale contributed to a quarter-end value decline of $61.96 million for Armstrong's position amid the company reporting full-year revenue of $1.6 billion, a 12% increase from the previous year. Armstrong's shares were valued at $163.86, reflecting a 16% gain over the past year, slightly outpacing the S&P 500's 15% gain.
Read More